Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Verrica Pharmaceuticals Inc. (VRCA) had Normalized Pre-Tax Income of $-0.27M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$14.34M |
|
$-0.27M |
|
$1.11M |
|
$13.23M |
|
$12.72M |
|
$1.63M |
|
$-1.90M |
|
$-0.27M |
|
|
Normalized Pre-Tax Income |
$-0.27M |
$-0.27M |
|
$-0.27M |
|
$-0.27M |
|
$-0.27M |
|
$1.63M |
|
$1.81M |
|
9.49M |
|
9.49M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$36.27M |
|
$0.23M |
|
$4.62M |
|
$40.90M |
|
$28.91M |
|
$22.25M |
|
$29.03M |
|
$57.94M |
|
$-17.04M |
|
$-17.04M |
|
$-17.04M |
|
9.49M |
|
| Cash Flow Statement Financials | |
$-13.04M |
|
$0.00M |
|
$-12.20M |
|
$46.33M |
|
$21.10M |
|
$-25.23M |
|
$2.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.25 |
|
-- |
|
-- |
|
4.27 |
|
-2.06 |
|
92.27% |
|
11.34% |
|
11.34% |
|
-- |
|
-1.91% |
|
-1.91% |
|
$-13.04M |
|
-- |
|
-- |
|
-- |
|
0.35 |
|
0.48 |
|
1.96 |
|
45.99 |
|
1.61% |
|
1.61% |
|
-0.67% |
|
-5.26% |
|
$-1.80 |
|
$-1.37 |
|
$-1.37 |
|